|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zong L, Abe M, Seto Y and Ji J: The
challenge of screening for early gastric cancer in China. Lancet.
388:26062016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Svoronos AA, Engelman DM and Slack FJ:
OncomiR or Tumor suppressor? The duplicity of microRNAs in cancer.
Cancer Res. 76:3666–3670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsai MM, Wang CS, Tsai CY, Huang HW, Chi
HC, Lin YH, Lu PH and Lin KH: Potential diagnostic, prognostic and
therapeutic targets of MicroRNAs in human gastric cancer. Int J Mol
Sci. 17(pii): E9452016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
da Silva Oliveira KC, Thomaz Araujo TM,
Albuquerque CI, Barata GA, Gigek CO, Leal MF, Wisnieski F,
Rodrigues Mello Junior FA, Khayat AS, de Assumpção PP, et al: Role
of miRNAs and their potential to be useful as diagnostic and
prognostic biomarkers in gastric cancer. World J Gastroenterol.
22:7951–7962. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishiguro H, Kimura M and Takeyama H: Role
of microRNAs in gastric cancer. World J Gastroenterol.
20:5694–5699. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Riquelme I, Letelier P, Riffo-Campos AL,
Brebi P and Roa JC: Emerging role of miRNAs in the drug resistance
of gastric cancer. Int J Mol Sci. 17:4242016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu HH, Lin WC and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shin VY, Ng EK, Chan VW, Kwong A and Chu
KM: A three-miRNA signature as promising non-invasive diagnostic
marker for gastric cancer. Mol Cancer. 14:2022015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu T, Wang LN, Li W, Zuo QF, Li MM, Zou QM
and Xiao B: Downregulation of miR-491-5p promotes gastric cancer
metastasis by regulating SNAIL and FGFR4. Cancer Sci.
109:1393–1403. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang C, Zhang CD, Ma MH and Dai DQ:
Three-microRNA signature identified by bioinformatics analysis
predicts prognosis of gastric cancer patients. World J
Gastroenterol. 24:1206–1215. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z and Ji F: Downregulation of
microRNA-17-5p inhibits drug resistance of gastric cancer cells
partially through targeting p21. Oncol Lett. 15:4585–4591.
2018.PubMed/NCBI
|
|
14
|
Shi R and Chiang VL: Facile means for
quantifying microRNA expression by real-time PCR. Biotechniques.
39:519–525. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang S, Han H, Hu Y, Yang W, Lv Y, Wang L,
Zhang L and Ji J: MicroRNA-130a-3p suppresses cell migration and
invasion by inhibition of TBL1XR1-mediated EMT in human gastric
carcinoma. Mol Carcinog. 57:383–392. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang D, Li R, Wang H, Wang J, Li Y, Wang
H, Wang W and Liu Z: Clinical significance of tumor necrosis factor
receptor 2 in middle and lower thoracic esophageal squamous cell
carcinoma. Oncol Lett. 16:2971–2978. 2018.PubMed/NCBI
|
|
19
|
Yoon J, Chung YE, Lim JS and Kim MJ:
Quantitative assessment of mesorectal fat: New prognostic biomarker
in patients with mid-to-lower rectal cancer. Eur Radiol.
29:1240–1247. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang S, Han H, Hu Y, Yang W, Lv Y, Wang L,
Zhang L and Ji J: SLC3A2, antigen of mAb 3G9, promotes migration
and invasion by upregulating of mucins in gastric cancer.
Oncotarget. 8:88586–88598. 2017.PubMed/NCBI
|
|
21
|
Endale Ahanda ML, Bienvenu T,
Sermet-Gaudelus I, Mazzolini L, Edelman A, Zoorob R and Davezac N:
The hsa-miR-125a/hsa-let-7e/hsa-miR-99b cluster is potentially
implicated in Cystic Fibrosis pathogenesis. J Cyst Fibros.
14:571–579. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gerrits A, Walasek MA, Olthof S, Weersing
E, Ritsema M, Zwart E, van Os R, Bystrykh LV and de Haan G: Genetic
screen identifies microRNA cluster 99b/let-7e/125a as a regulator
of primitive hematopoietic cells. Blood. 119:377–387. 2018.
View Article : Google Scholar
|
|
23
|
Guo S, Lu J, Schlanger R, Zhang H, Wang
JY, Fox MC, Purton LE, Fleming HH, Cobb B, Merkenschlager M, et al:
MicroRNA miR-125a controls hematopoietic stem cell number. Proc
Natl Acad Sci USA. 107:14229–14234. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de la Rica L, Garcia-Gomez A, Comet NR,
Rodríguez-Ubreva J, Ciudad L, Vento-Tormo R, Company C,
Álvarez-Errico D, García M, Gómez-Vaquero C and Ballestar E:
NF-κB-direct activation of microRNAs with repressive effects on
monocyte-specific genes is critical for osteoclast differentiation.
Genome Biol. 16:22015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma J, Zhan Y, Xu Z, Li Y, Luo A, Ding F,
Cao X, Chen H and Liu Z: ZEB1 induced miR-99b/let-7e/miR-125a
cluster promotes invasion and metastasis in esophageal squamous
cell carcinoma. Cancer Lett. 398:37–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hisaoka M, Matsuyama A, Nagao Y, Luan L,
Kuroda T, Akiyama H, Kondo S and Hashimoto H: Identification of
altered MicroRNA expression patterns in synovial sarcoma. Genes
Chromosomes Cancer. 50:137–145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu G, Ma Y, Jia C, Yang H, Xie R, Luo P,
Chai L, Cai H, Cai M, Lv Z, et al: Reduced miR-125a levels
associated with poor survival of patients with hepatocellular
cancer. Oncol Lett. 14:5952–5958. 2017.PubMed/NCBI
|
|
28
|
Zhong L, Sun S, Shi J, Cao F, Han X and
Chen Z: MicroRNA-125a-5p plays a role as a tumor suppressor in lung
carcinoma cells by directly targeting STAT3. Tumour Biol.
39:10104283176975792017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Xue C, Zhu X, Zhu X, Xian H and
Huang Z: Suppression of microRNA-125a-5p upregulates the TAZ-EGFR
signaling pathway and promotes retinoblastoma proliferation. Cell
Signal. 28:850–860. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qin X, Wan Y, Wang S and Xue M:
MicroRNA-125a-5p modulates human cervical carcinoma proliferation
and migration by targeting ABL2. Drug Des Devel Ther. 10:71–79.
2015.PubMed/NCBI
|
|
31
|
Cao Y, Tan S, Tu Y, Zhang G, Liu Y, Li D,
Xu S, Le Z, Xiong J, Zou W, et al: MicroRNA-125a-5p inhibits
invasion and metastasis of gastric cancer cells by targeting BRMS1
expression. Oncol Lett. 15:5119–5130. 2018.PubMed/NCBI
|
|
32
|
Nishida N, Mimori K, Fabbri M, Yokobori T,
Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y and Mori M:
MicroRNA-125a-5p is an independent prognostic factor in gastric
cancer and inhibits the proliferation of human gastric cancer cells
in combination with trastuzumab. Clin Cancer Res. 17:2725–2733.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fassan M, Pizzi M, Realdon S, Balistreri
M, Guzzardo V, Zagonel V, Castoro C, Mastracci L, Farinati F, Nitti
D, et al: The HER2-miR125a5p/miR125b loop in gastric and esophageal
carcinogenesis. Hum Pathol. 44:1804–1810. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu Y, Huang Z and Liu Y: Reduced
miR-125a-5p expression is associated with gastric carcinogenesis
through the targeting of E2F3. Mol Med Rep. 10:2601–2608. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hashiguchi Y, Nishida N, Mimori K, Sudo T,
Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y and Mori
M: Down-regulation of miR-125a-3p in human gastric cancer and its
clinicopathological significance. Int J Oncol. 40:1477–1482.
2012.PubMed/NCBI
|
|
36
|
Dai J, Wang J, Yang L, Xiao Y and Ruan Q:
miR-125a regulates angiogenesis of gastric cancer by targeting
vascular endothelial growth factor A. Int J Oncol. 47:1801–1810.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen J, Ouyang H, An X and Liu S: miR-125a
is upregulated in cancer stem-like cells derived from TW01 and is
responsible for maintaining stemness by inhibiting p53. Oncol Lett.
17:87–94. 2019.PubMed/NCBI
|
